Type IV collagen as a potential biomarker of metastatic breast cancer

No reliable, non-invasive biomarker of metastatic breast cancer (mBC) exists: circulating CA15-3 (cCA15-3) is the marker mostly used to monitor mBC. Circulating collagen IV (cCOLIV) has been evaluated in other metastatic cancers and has been found to be a promising biomarker. The overarching aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindgren, Moa, Jansson, Malin, Tavelin, Björn, Dirix, Luc, Vermeulen, Peter, Nyström, Hanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987628/
https://www.ncbi.nlm.nih.gov/pubmed/33655422
http://dx.doi.org/10.1007/s10585-021-10082-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987628/
https://www.ncbi.nlm.nih.gov/pubmed/33655422
http://dx.doi.org/10.1007/s10585-021-10082-2

Ejemplares similares